Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 282

1.

Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Butterfield JM, Tsuji BT, Brown J, Ashley ED, Hardy D, Brown K, Forrest A, Lodise TP.

Antimicrob Agents Chemother. 2011 Dec;55(12):5433-7. doi: 10.1128/AAC.00407-11. Epub 2011 Sep 19.

2.

Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.

J Antimicrob Chemother. 2011 Jul;66(7):1594-9. doi: 10.1093/jac/dkr169. Epub 2011 Apr 26.

PMID:
21525024
3.
4.

Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.

Sancak B, Yagci S, Gür D, Gülay Z, Ogunc D, Söyletir G, Yalcin AN, Dündar DO, Topçu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V.

BMC Infect Dis. 2013 Dec 10;13:583. doi: 10.1186/1471-2334-13-583.

5.

Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.

Takata T, Miyazaki M, Futo M, Hara S, Shiotsuka S, Kamimura H, Yoshimura H, Matsunaga A, Nishida T, Ishikura H, Ishikawa T, Tamura K, Tsuji BT.

Scand J Infect Dis. 2013 Mar;45(3):203-12. doi: 10.3109/00365548.2012.723221. Epub 2012 Oct 31.

PMID:
23113753
6.

Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?

de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD.

Diagn Mol Pathol. 2011 Sep;20(3):184-8. doi: 10.1097/PDM.0b013e318208fc47.

PMID:
21817905
7.

Determining vancomycin Etest MICs in patients with MRSA bloodstream infection does not support switching antimicrobials.

Hos NJ, Jazmati N, Stefanik D, Hellmich M, AlSael H, Kern WV, Rieg S, Wisplinghoff H, Seifert H, Kaasch AJ.

J Infect. 2017 Mar;74(3):248-259. doi: 10.1016/j.jinf.2016.12.007. Epub 2016 Dec 22.

PMID:
28017826
8.

Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Moise PA, Smyth DS, El-Fawal N, Robinson DA, Holden PN, Forrest A, Sakoulas G.

J Antimicrob Chemother. 2008 Jan;61(1):85-90. Epub 2007 Nov 27.

PMID:
18042628
9.

Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.

Seidl K, Chen L, Bayer AS, Hady WA, Kreiswirth BN, Xiong YQ.

Antimicrob Agents Chemother. 2011 Dec;55(12):5631-9. doi: 10.1128/AAC.05251-11. Epub 2011 Oct 3.

10.

Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia.

Han JH, Edelstein PH, Lautenbach E.

J Antimicrob Chemother. 2012 Oct;67(10):2346-9. doi: 10.1093/jac/dks255. Epub 2012 Jul 3.

11.

Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin .

Lodise TP, Drusano GL, Lazariu V, El-Fawal N, Evans A, Graffunder E, Stellrecht K, Mendes RE, Jones RN, Cosler L, McNutt LA.

J Antimicrob Chemother. 2014 Sep;69(9):2547-55. doi: 10.1093/jac/dku135. Epub 2014 May 19.

PMID:
24840624
12.

Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.

Musta AC, Riederer K, Shemes S, Chase P, Jose J, Johnson LB, Khatib R.

J Clin Microbiol. 2009 Jun;47(6):1640-4. doi: 10.1128/JCM.02135-08. Epub 2009 Apr 15.

13.

Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.

Tsao SM, Wang WY, Ko WC, Huang CH, Lu CT, Chuang YC, Liu CY, Liao CH, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Chen YH, Lu PL, Thomas CY, Hsueh PR.

Diagn Microbiol Infect Dis. 2014 Oct;80(2):162-7. doi: 10.1016/j.diagmicrobio.2014.06.007. Epub 2014 Jun 21.

PMID:
25053202
14.

Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.

Lin SY, Chen TC, Chen FJ, Chen YH, Lin YI, Siu LK, Lu PL.

J Microbiol Immunol Infect. 2012 Dec;45(6):435-41. doi: 10.1016/j.jmii.2012.05.004. Epub 2012 Jun 30.

15.
16.

Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus.

Park MJ, Kim HS, Kim HS, Kim JS, Song W, Kim MY, Lee YK, Kang HJ.

Ann Lab Med. 2015 Jul;35(4):399-403. doi: 10.3343/alm.2015.35.4.399. Epub 2015 May 21.

17.

Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.

Rojas L, Bunsow E, Muñoz P, Cercenado E, Rodríguez-Créixems M, Bouza E.

J Antimicrob Chemother. 2012 Jul;67(7):1760-8. doi: 10.1093/jac/dks128. Epub 2012 May 3.

PMID:
22556382
18.

Vancomycin heteroresistance is associated with reduced mortality in ST239 methicillin-resistant Staphylococcus aureus blood stream infections.

van Hal SJ, Jones M, Gosbell IB, Paterson DL.

PLoS One. 2011;6(6):e21217. doi: 10.1371/journal.pone.0021217. Epub 2011 Jun 21.

19.
20.

Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.

Kan LP, Lin JC, Chiu SK, Yeh YC, Lin TY, Yang YS, Wang YC, Wang NC, Yeh KM, Chang FY.

J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.

Supplemental Content

Support Center